Skip to main content
Clinical Trials/NCT03378258
NCT03378258
Completed
Not Applicable

Petechiae In Children (PIC) Study

Belfast Health and Social Care Trust1 site in 1 country1,329 target enrollmentNovember 9, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Meningitis, Meningococcal
Sponsor
Belfast Health and Social Care Trust
Enrollment
1329
Locations
1
Primary Endpoint
Confirmation of meningococcal infection
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

A fever and a non-blanching rash is a relatively common reason for a child to attend an emergency department. A fever and a non-blanching rash can be an early sign of a life-threatening infection known as meningococcal disease. The aim of the PIC study is to determine how best to diagnose early meningococcal disease in children.

In particular the investigators are interested in researching how quick bedside tests can be used to do this.

Detailed Description

A fever an a non-blanching rash is a relatively common presentation the the emergency department. A minority of children with a fever and a non-blanching rash with have a life-threatening infection. Currently it is very difficult to determine those children that require urgent treatment from those that have a simple viral illness. The aim of the PIC study is to research how to better diagnose those serious infections earlier. Data from the study will be used to test the effectiveness of current practice and to identify areas where current practice could be improved.

Registry
clinicaltrials.gov
Start Date
November 9, 2017
End Date
June 30, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Fever (recorded or reported) 38 degrees Centigrade or higher and a non-blanching rash (at the time of presentation)
  • Features of meningococcal sepsis/meningitis

Exclusion Criteria

  • Known haematological conditions such as haematological malignancy, idiopathic thrombocytopenic purpura and coagulopathy

Outcomes

Primary Outcomes

Confirmation of meningococcal infection

Time Frame: 72 hours from testing

Blood and Cerebrospinal fluid (CSF) culture or quantitative Polymerase Chain Reaction (PCR) will be used to confirm meningococcal infection

Study Sites (1)

Loading locations...

Similar Trials